Clinical Trials Logo

Clinical Trial Summary

The aim of this observational study is to evaluate the prevalence of uncomplicated pregnancies in women suffering from congenital fibrinogen disorders (i.e, hypofibrinogenemia, dysfibrinogenemia, hypodysfibrinogenemia) as well as to describe pregnancies outcomes in such diseases.


Clinical Trial Description

Women with quantitative or qualitative fibrinogen disorders are often more prone to obstetrical complications, from bleeding to recurrent miscarriages or thrombosis. Data on fibrinogen levels variations throughout the pregnancy and on the delivery management are lacking. In this observational study will be include adult women with pas obstetrical history. A general questionnaire on demographics and clinical data will be filled out by the patient's physician. A detailed questionnaire on obstetrical data will also be completed contacting the patient in case of lacking data. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03920332
Study type Observational
Source University Hospital, Geneva
Contact
Status Completed
Phase
Start date September 1, 2019
Completion date May 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT03484065 - Quality of Life in Patients With Congenital Afibrinogenemia
Completed NCT02094430 - Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency Phase 2/Phase 3